The Certainty Framework for Assessing Real‐World Data in Studies of Medical Product Safety and Effectiveness
Noelle M. Cocoros(Harvard University), Sengwee Toh(Harvard University), Miriam Sturkenboom(University Medical Center Utrecht), Chieko Ishiguro(Pharmaceuticals and Medical Devices Agency), Solomon Iyasu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter Arlett(European Medicines Agency), Wei Zhou(Broad Institute), Nancy A Dreyer(IQVIA (United Kingdom))
Cited by 23
Related Papers
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
H1N1 2009 influenza virus infection during pregnancy in the USA
|The Lancet|2009|1.4k
Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study
|BMJ|2016|284
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
|Proceedings of the National Academy of Sciences|2011|256
Rapidly in Situ Forming Biodegradable Robust Hydrogels by Combining Stereocomplexation and Photopolymerization
|Journal of the American Chemical Society|2007|156